Rare diseases
Investigational molecules
Locations
Back to France263 clinical trials in Avignon, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Sibeprenlimab for Patients with IgA Nephropathy
FranceStudy on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment
FranceStudy of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
FranceStudy Comparing Olaparib and Pembrolizumab with Chemotherapy and Pembrolizumab for Patients with Advanced Triple-Negative Breast Cancer
FranceStudy on MK-7684A and Docetaxel for Treating Metastatic Non-Small Cell Lung Cancer in Patients After Platinum Chemotherapy and Immunotherapy
FranceStudy on Atezolizumab, Bevacizumab, and Paclitaxel for Advanced Lung Cancer Patients After Immunotherapy and Chemotherapy
FranceStudy of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy
FranceStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels
FranceStudy Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment
FranceStudy of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer
FranceComparing inavolisib plus fulvestrant versus alpelisib plus fulvestrant in patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation
FranceStudy Comparing Pembrolizumab and Lenvatinib with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on head and neck cancers, gastric cancer, and pancreatic adenocarcinoma. Studies evaluate novel combination therapies and targeted treatments to improve patient outcomes.
Multiple trials investigating breakthrough treatments for locally advanced and metastatic diseases.
Groundbreaking research in multiple myeloma and lymphoma treatments, exploring novel therapeutic approaches and combination strategies.
Focus on improving treatment outcomes for both newly diagnosed and relapsed patients.
Comprehensive studies of non-small cell lung cancer treatments, investigating immunotherapy combinations and personalized treatment approaches.
Emphasis on developing more effective and tolerable treatment regimens.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
